STXS
Stereotaxis, Inc.
Price Chart
Latest Quote
$1.88
+0.10 (+5.62%)
Current Price
| Previous Close | $1.78 |
| Open | $1.84 |
| Day High | $1.91 |
| Day Low | $1.77 |
| Volume | 584,789 |
Stock Information
| Shares Outstanding | 97.74M |
| Total Debt | $5.28M |
| Cash Equivalents | $14.62M |
| Revenue | $31.20M |
| Net Income | $-22.95M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $183.75M |
| EPS (TTM) | $-0.24 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $173.78M |
| Sales | $31.20M |
| Income | $-22.95M |
| Book/sh | $0.14 |
| Cash/sh | $0.15 |
| Employees | 131 |
Financial Ratios
| Quick Ratio | 1.05 |
| Current Ratio | 1.56 |
| Debt/Eq | 26.94 |
Returns & Margins
| ROA | -24.74% |
| ROE | -156.12% |
| Gross Margin | 53.86% |
| Operating Margin | -83.06% |
| Profit Margin | -69.50% |
Ownership
| Insider Ownership | 15.37% |
| Institutional Ownership | 44.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -14.84 |
| PEG | 1.31 |
| P/S | 5.89 |
| P/B | 13.33 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $4.12 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 31.48 |
| ATR | nan |
| Shares Float | 69.08M |
| Short Float | 4.71% |
| Short Ratio | 10.64 |
| Volatility | 1.32 |
| Rel Volume | 1.63 |
Performance History
| Week | +3.30% |
| Month | +8.67% |
| Quarter | +3.30% |
| 6 Months | -21.01% |
| YTD | -18.97% |
| Year | -17.18% |
| 3 Years | -7.84% |
| 5 Years | -77.49% |
| 10 Years | +82.52% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.88 | 814,300 |
| 2026-06-17 | $1.78 | 308,000 |
| 2026-06-16 | $1.82 | 348,300 |
| 2026-06-15 | $1.84 | 262,200 |
| 2026-06-12 | $1.84 | 204,900 |
| 2026-06-11 | $1.82 | 201,400 |
| 2026-06-10 | $1.81 | 305,200 |
| 2026-06-09 | $1.85 | 206,200 |
| 2026-06-08 | $1.81 | 307,000 |
| 2026-06-05 | $1.78 | 591,000 |
| 2026-06-04 | $1.88 | 289,200 |
| 2026-06-03 | $1.84 | 615,600 |
| 2026-06-02 | $1.97 | 253,600 |
| 2026-06-01 | $1.94 | 345,100 |
| 2026-05-29 | $1.98 | 361,300 |
| 2026-05-28 | $2.08 | 431,600 |
| 2026-05-27 | $2.01 | 503,400 |
| 2026-05-26 | $1.95 | 258,200 |
| 2026-05-22 | $1.92 | 408,900 |
| 2026-05-21 | $1.90 | 369,500 |
| 2026-05-20 | $1.85 | 407,400 |
| 2026-05-19 | $1.73 | 315,100 |
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
đ° Latest News
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
Zacks âĸ 2026-06-15T14:31:00Z
ISRG's Ion Platform: A Major Growth Engine in Lung Cancer Care?
Zacks âĸ 2026-05-25T15:16:00Z
Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why
Insider Monkey âĸ 2026-05-24T13:06:03Z
Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigating Regulatory Wins and Revenue ...
GuruFocus.com âĸ 2026-05-13T05:02:13ZStereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-12T21:40:06Z
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T23:05:22Z
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-06T22:30:07Z
Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates
Zacks âĸ 2026-05-05T11:25:02Z
Why Stereotaxis (STXS) Could Be One of the Best Robotics Stocks to Buy Under $30
Insider Monkey âĸ 2026-05-01T14:46:14Z
Stereotaxis Stock Up on First U.S. MAGiC Procedures Post Approval
Zacks âĸ 2026-04-23T16:04:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $15,306,000 | $12,324,000 | $11,911,000 | $9,677,000 |
| Cost Of Revenue | $15,306,000 | $12,324,000 | $11,911,000 | $9,677,000 |
| Total Revenue | $32,377,000 | $26,918,000 | $26,771,000 | $28,147,000 |
| Operating Revenue | $32,377,000 | $26,918,000 | $26,771,000 | $28,147,000 |
| Expenses | ||||
| Total Expenses | $54,489,000 | $51,657,000 | $48,610,000 | $46,923,000 |
| Other Income Expense | $2,000 | - | $30,000 | - |
| Other Non Operating Income Expenses | $2,000 | - | $30,000 | - |
| Net Non Operating Interest Income Expense | $467,000 | $694,000 | $1,096,000 | $484,000 |
| Operating Expense | $39,183,000 | $39,333,000 | $36,699,000 | $37,246,000 |
| Other Operating Expenses | $-492,000 | - | - | - |
| Selling And Marketing Expense | $12,443,000 | $12,372,000 | $12,376,000 | $12,325,000 |
| General And Administrative Expense | $17,849,000 | $17,201,000 | $14,050,000 | $14,363,000 |
| Rent Expense Supplemental | - | - | - | $0 |
| Total Other Finance Cost | - | - | - | $-484,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Net Interest Income | $467,000 | $694,000 | $1,096,000 | $484,000 |
| Interest Income | $467,000 | $694,000 | $1,096,000 | $484,000 |
| Normalized Income | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Net Income From Continuing And Discontinued Operation | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Total Operating Income As Reported | $-22,112,000 | $-24,739,000 | $-21,839,000 | $-18,776,000 |
| Net Income Common Stockholders | $-22,914,000 | $-25,353,000 | $-22,056,000 | $-19,635,000 |
| Net Income | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Net Income Including Noncontrolling Interests | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Net Income Continuous Operations | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Pretax Income | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Interest Income Non Operating | $467,000 | $694,000 | $1,096,000 | $484,000 |
| Operating Income | $-22,112,000 | $-24,739,000 | $-21,839,000 | $-18,776,000 |
| Gross Profit | $17,071,000 | $14,594,000 | $14,860,000 | $18,470,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.25 | $-0.30 | $-0.27 | $-0.26 |
| Basic EPS | $-0.25 | $-0.30 | $-0.27 | $-0.26 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,557,000 | $-23,770,000 | $-21,244,000 | $-18,347,000 |
| Reconciled Depreciation | $1,555,000 | $969,000 | $595,000 | $429,000 |
| EBITDA (Bullshit earnings) | $-20,557,000 | $-23,770,000 | $-21,244,000 | $-18,347,000 |
| EBIT | $-22,112,000 | $-24,739,000 | $-21,839,000 | $-18,776,000 |
| Diluted Average Shares | $90,957,313 | $85,183,306 | $80,702,358 | $76,061,183 |
| Basic Average Shares | $90,957,313 | $85,183,306 | $80,702,358 | $76,061,183 |
| Diluted NI Availto Com Stockholders | $-22,914,000 | $-25,353,000 | $-22,056,000 | $-19,635,000 |
| Preferred Stock Dividends | $1,271,000 | $1,308,000 | $1,343,000 | $1,343,000 |
| Research And Development | $9,383,000 | $9,760,000 | $10,273,000 | $10,558,000 |
| Selling General And Administration | $30,292,000 | $29,573,000 | $26,426,000 | $26,688,000 |
| Other Gand A | $17,849,000 | $17,201,000 | $14,050,000 | $14,363,000 |
| Total Unusual Items | - | - | - | $0 |
| Total Unusual Items Excluding Goodwill | - | - | - | $0 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $8,528,000 | $310,000 | $21,920,000 | $31,929,000 |
| Total Assets | $52,251,000 | $46,724,000 | $41,909,000 | $53,413,000 |
| Total Non Current Assets | $18,402,000 | $20,285,000 | $8,642,000 | $10,167,000 |
| Other Non Current Assets | $278,000 | $107,000 | $356,000 | $952,000 |
| Goodwill And Other Intangible Assets | $10,193,000 | $11,122,000 | $0 | - |
| Other Intangible Assets | $6,429,000 | $7,358,000 | - | - |
| Current Assets | $33,849,000 | $26,439,000 | $33,267,000 | $43,246,000 |
| Other Current Assets | $698,000 | $1,848,000 | $98,000 | $72,000 |
| Restricted Cash | $0 | $219,000 | $525,000 | $525,000 |
| Inventory | $9,567,000 | $8,331,000 | $8,426,000 | $7,876,000 |
| Receivables | $10,163,000 | $3,824,000 | $3,822,000 | $5,090,000 |
| Other Receivables | $4,316,000 | - | - | - |
| Accounts Receivable | $5,847,000 | $3,824,000 | $3,822,000 | $5,090,000 |
| Allowance For Doubtful Accounts Receivable | $-541,000 | $-582,000 | $-672,000 | $-235,000 |
| Gross Accounts Receivable | $6,388,000 | $4,406,000 | $4,494,000 | $5,325,000 |
| Cash Cash Equivalents And Short Term Investments | $13,421,000 | $12,217,000 | $19,818,000 | $28,430,000 |
| Cash And Cash Equivalents | $13,421,000 | $12,217,000 | $19,818,000 | $8,586,000 |
| Cash Equivalents | $12,096,000 | $11,248,000 | - | $5,328,000 |
| Cash Financial | $1,325,000 | $969,000 | - | $3,258,000 |
| Current Deferred Assets | - | $1,025,000 | $0 | - |
| Prepaid Assets | - | $787,000 | $578,000 | $1,253,000 |
| Debt | ||||
| Total Debt | $5,436,000 | $6,006,000 | $5,490,000 | $5,861,000 |
| Long Term Debt And Capital Lease Obligation | $4,794,000 | $5,436,000 | $5,062,000 | $5,488,000 |
| Current Debt And Capital Lease Obligation | $642,000 | $570,000 | $428,000 | $373,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $33,530,000 | $35,292,000 | $19,989,000 | $21,484,000 |
| Total Non Current Liabilities Net Minority Interest | $11,170,000 | $13,690,000 | $6,742,000 | $7,193,000 |
| Other Non Current Liabilities | $4,724,000 | $6,126,000 | $43,000 | $51,000 |
| Non Current Deferred Liabilities | $555,000 | $2,064,000 | $1,637,000 | $1,654,000 |
| Current Liabilities | $22,360,000 | $21,602,000 | $13,247,000 | $14,291,000 |
| Other Current Liabilities | $4,894,000 | $5,638,000 | - | - |
| Current Deferred Liabilities | $6,720,000 | $7,849,000 | $7,702,000 | $8,387,000 |
| Payables And Accrued Expenses | $10,104,000 | $7,545,000 | $5,117,000 | $5,531,000 |
| Payables | $4,830,000 | $5,754,000 | $3,190,000 | $3,270,000 |
| Total Tax Payable | $62,000 | $86,000 | - | $47,000 |
| Accounts Payable | $4,768,000 | $5,668,000 | $3,190,000 | $3,270,000 |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $13,481,000 | $6,080,000 | $16,343,000 | $26,340,000 |
| Preferred Stock Equity | $5,240,000 | $5,352,000 | $5,577,000 | $5,589,000 |
| Total Equity Gross Minority Interest | $18,721,000 | $11,432,000 | $21,920,000 | $31,929,000 |
| Stockholders Equity | $18,721,000 | $11,432,000 | $21,920,000 | $31,929,000 |
| Retained Earnings | $-583,368,000 | $-561,725,000 | $-537,680,000 | $-516,967,000 |
| Other | ||||
| Treasury Shares Number | $4,015 | $4,015 | $4,015 | $4,015 |
| Ordinary Shares Number | $95,335,613 | $85,322,542 | $80,945,682 | $74,870,444 |
| Share Issued | $95,339,628 | $85,326,557 | $80,949,697 | $74,874,459 |
| Tangible Book Value | $3,288,000 | $-5,042,000 | $16,343,000 | $26,340,000 |
| Invested Capital | $13,481,000 | $6,080,000 | $16,343,000 | $26,340,000 |
| Working Capital | $11,489,000 | $4,837,000 | $20,020,000 | $28,955,000 |
| Capital Lease Obligations | $5,436,000 | $6,006,000 | $5,490,000 | $5,861,000 |
| Total Capitalization | $18,721,000 | $11,432,000 | $21,920,000 | $31,929,000 |
| Treasury Stock | $206,000 | $206,000 | $206,000 | $206,000 |
| Additional Paid In Capital | $596,960,000 | $567,926,000 | $554,148,000 | $543,438,000 |
| Capital Stock | $5,335,000 | $5,437,000 | $5,658,000 | $5,664,000 |
| Common Stock | $95,000 | $85,000 | $81,000 | $75,000 |
| Preferred Stock | $5,240,000 | $5,352,000 | $5,577,000 | $5,589,000 |
| Non Current Accrued Expenses | $1,097,000 | $64,000 | - | $51,000 |
| Non Current Deferred Revenue | $555,000 | $2,064,000 | $1,637,000 | $1,654,000 |
| Long Term Capital Lease Obligation | $4,794,000 | $5,436,000 | $5,062,000 | $5,488,000 |
| Current Deferred Revenue | $6,720,000 | $7,849,000 | $7,702,000 | $8,387,000 |
| Current Capital Lease Obligation | $642,000 | $570,000 | $428,000 | $373,000 |
| Current Accrued Expenses | $5,274,000 | $1,791,000 | $1,927,000 | $2,261,000 |
| Goodwill | $3,764,000 | $3,764,000 | - | - |
| Net PPE | $7,931,000 | $9,056,000 | $8,286,000 | $9,215,000 |
| Accumulated Depreciation | $-4,816,000 | $-4,441,000 | $-3,876,000 | $-3,458,000 |
| Gross PPE | $12,747,000 | $13,497,000 | $12,162,000 | $12,673,000 |
| Leases | $2,916,000 | $2,916,000 | $2,911,000 | $2,692,000 |
| Other Properties | $9,831,000 | $10,581,000 | $9,251,000 | $9,777,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-2,591,000 | $-2,377,000 | $-1,939,000 | $-1,907,000 |
| Finished Goods | $3,413,000 | $4,382,000 | $3,413,000 | $2,697,000 |
| Work In Process | $2,230,000 | $1,103,000 | $1,034,000 | $530,000 |
| Raw Materials | $6,515,000 | $5,223,000 | $5,918,000 | $6,556,000 |
| Construction In Progress | - | - | $0 | $204,000 |
| Other Short Term Investments | - | - | $0 | $19,844,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,778,000 | $-8,531,000 | $-9,505,000 | $-10,793,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,685,000 | $-8,497,000 | $-9,139,000 | $-8,415,000 |
| Cash Flow From Continuing Operating Activities | $-13,685,000 | $-8,497,000 | $-9,139,000 | $-8,415,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-93,000 | $-34,000 | $-366,000 | $-2,378,000 |
| Investing Cash Flow | $-93,000 | $74,000 | $19,765,000 | $-22,094,000 |
| Cash Flow From Continuing Investing Activities | $-93,000 | $74,000 | $19,765,000 | $-22,094,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $15,656,000 | $297,000 | $81,000 | $220,000 |
| Financing Cash Flow | $14,763,000 | $297,000 | $81,000 | $220,000 |
| Cash Flow From Continuing Financing Activities | $14,763,000 | $297,000 | $81,000 | $220,000 |
| Net Other Financing Charges | $-893,000 | - | - | - |
| Net Common Stock Issuance | $15,656,000 | $297,000 | $81,000 | $220,000 |
| Common Stock Issuance | $15,656,000 | $297,000 | $81,000 | $220,000 |
| Other | ||||
| End Cash Position | $13,421,000 | $12,436,000 | $20,562,000 | $9,855,000 |
| Beginning Cash Position | $12,436,000 | $20,562,000 | $9,855,000 | $40,144,000 |
| Changes In Cash | $985,000 | $-8,126,000 | $10,707,000 | $-30,289,000 |
| Net Business Purchase And Sale | $0 | $108,000 | $0 | - |
| Sale Of Business | $0 | $108,000 | $0 | - |
| Net PPE Purchase And Sale | $-93,000 | $-34,000 | $-366,000 | $-2,378,000 |
| Purchase Of PPE | $-93,000 | $-34,000 | $-366,000 | $-2,378,000 |
| Change In Working Capital | $-5,621,000 | $2,505,000 | $612,000 | $-1,103,000 |
| Change In Other Working Capital | $-2,638,000 | $574,000 | $-702,000 | $989,000 |
| Change In Other Current Liabilities | $-13,000 | $21,000 | $-8,000 | $-167,000 |
| Change In Other Current Assets | $-170,000 | $29,000 | $71,000 | $70,000 |
| Change In Payables And Accrued Expense | $-692,000 | $659,000 | $-116,000 | $-436,000 |
| Change In Accrued Expense | $188,000 | $-99,000 | $-334,000 | $-267,000 |
| Change In Payable | $-880,000 | $758,000 | $218,000 | $-169,000 |
| Change In Account Payable | $-880,000 | $758,000 | $218,000 | $-169,000 |
| Change In Prepaid Assets | $1,151,000 | $-146,000 | $649,000 | $1,031,000 |
| Change In Inventory | $-1,236,000 | $677,000 | $-550,000 | $-2,906,000 |
| Change In Receivables | $-2,023,000 | $691,000 | $1,268,000 | $316,000 |
| Changes In Account Receivables | $-2,023,000 | $691,000 | $1,268,000 | $316,000 |
| Other Non Cash Items | $2,172,000 | $1,812,000 | $31,000 | $103,000 |
| Stock Based Compensation | $9,852,000 | $10,262,000 | $10,623,000 | $10,576,000 |
| Depreciation Amortization Depletion | $1,555,000 | $969,000 | $595,000 | $429,000 |
| Depreciation And Amortization | $1,555,000 | $969,000 | $595,000 | $429,000 |
| Amortization Cash Flow | $929,000 | $382,000 | $0 | - |
| Amortization Of Intangibles | $929,000 | $382,000 | $0 | - |
| Depreciation | $626,000 | $587,000 | $595,000 | $429,000 |
| Net Income From Continuing Operations | $-21,643,000 | $-24,045,000 | $-20,713,000 | $-18,292,000 |
| Net Investment Purchase And Sale | - | $0 | $20,131,000 | $-19,716,000 |
| Sale Of Investment | - | $0 | $20,131,000 | $0 |
| Amortization Of Securities | - | $0 | $-287,000 | $-128,000 |
| Purchase Of Investment | - | - | $0 | $-19,716,000 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-18